FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

DuPont Nutrition Avicel DG Recall

Avicel DG, MCC/Dibasic Calcium Phosphate

DuPont Nutrition USA, Inc · Newark, DE

Risk level
Class III
Reported by FDA
May 3, 2023
Recall ID
D-0547-2023
Check your lot numberHow we source this data

Summary

DuPont Nutrition recalled Avicel DG starting Apr 13, 2023. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0547-2023 on May 3, 2023. Reason: Failed Impurities/Degradation Specifications: Out of specification results obtained for conductivity. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation Specifications: Out of specification results obtained for conductivity.

Product description

Avicel DG, MCC/Dibasic Calcium Phosphate, Net Content/Gross Weight 20.0 KG / 21.1 KG bulk container, Manufactured by: DuPont Nutrition USA, Inc., 1301 Ogletown Road, Newark, DE 19711, USA; Manufactured in USA; Headquarters: DuPont Nutrition Biosciences ApS, Langebrogade 1, Copenhagen, Denmark.

Lot numbers, UPCs & expiration codes

Batch Numbers: 2213749659, 2213766837, 2213776558, 2213776559

Where it was sold

Nationwide in the USA, Malta, Canada, China, Peru, Mexico, Australia, Saudi Arabia, Spain, Dominican Republic, Puerto Rico, Singapore, Bangkok, Ireland, India, and Columbia.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0547-2023
Classification
Class III
Status
Terminated
Recall initiated
Apr 13, 2023
FDA report date
May 3, 2023
Quantity
23,060 kg in bulk drums, boxes & sacks
Recall type
Voluntary: Firm initiated
Recalling firm
DuPont Nutrition USA, Inc

Original FDA data

Every field from FDA enforcement report D-0547-2023, exactly as published.

Show all FDA fields
City
Newark
State
DE
Status
Terminated
Country
United States
Event ID
92120
Address
1301 Ogletown Rd
Code information
Batch Numbers: 2213749659, 2213766837, 2213776558, 2213776559
Postal code
19711-5419
Report date
May 3, 2023
Product type
Drugs
Recall number
D-0547-2023
Classification
Class III
Recalling firm
DuPont Nutrition USA, Inc
Product quantity
23,060 kg in bulk drums, boxes & sacks
Termination date
Mar 4, 2024
Reason for recall
Failed Impurities/Degradation Specifications: Out of specification results obtained for conductivity.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Avicel DG, MCC/Dibasic Calcium Phosphate, Net Content/Gross Weight 20.0 KG / 21.1 KG bulk container, Manufactured by: DuPont Nutrition USA, Inc., 1301 Ogletown Road, Newark, DE 19711, USA; Manufactured in USA; Headquarters: DuPont Nutrition Biosciences ApS, Langebrogade 1, Copenhagen, Denmark.
Distribution pattern
Nationwide in the USA, Malta, Canada, China, Peru, Mexico, Australia, Saudi Arabia, Spain, Dominican Republic, Puerto Rico, Singapore, Bangkok, Ireland, India, and Columbia.
Recall initiation date
Apr 13, 2023
Initial firm notification
Letter
Center classification date
Apr 25, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0547-2023, published May 3, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls